EBR Systems sets one-for-10 reverse stock split and adjusts CDI conversion ratio

An update from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) is now available.

EBR Systems, developer of the WiSE wireless cardiac pacing technology for heart failure patients, will implement a one-for-10 reverse stock split of its common shares following stockholder approval. The company’s ASX-traded CHESS Depositary Interests will not be consolidated; instead, the CDI-to-share conversion ratio will change from 1-to-1 to 10-to-1, leaving the value per CDI and holders’ CDI counts largely unchanged aside from minor rounding.

Under the plan, fractional entitlements from the reverse split will be rounded up to the nearest whole share, with corresponding CDI holdings rounded to the nearest multiple of 10 under the new ratio. An implementation timetable running from late March to mid-April 2026 outlines the transition to post-split trading, cross-border movements between registers, and resumption of normal T+2 trading, providing clarity for investors on the operational impact of the capital restructure.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.47 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a Silicon Valley-based medical technology company focused on treating cardiac rhythm disease with its proprietary Wireless Stimulation Endocardially (WiSE) technology. Its lead product is a wireless, endocardial left ventricular pacing system aimed at heart failure patients requiring cardiac resynchronisation therapy, with future applications targeted at bradycardia and other non-cardiac indications.

Average Trading Volume: 499,849

Technical Sentiment Signal: Sell

Current Market Cap: A$301.7M

For a thorough assessment of EBR stock, go to TipRanks’ Stock Analysis page.